| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 22.261 | 26.689 | 31.027 | 37.804 | 44.605 | 38.730 | 33.528 | 42.201 | 49.084 | 48.307 |
| Total Income - EUR | 22.261 | 26.689 | 31.028 | 37.834 | 44.606 | 38.731 | 33.530 | 42.202 | 49.085 | 48.308 |
| Total Expenses - EUR | 15.399 | 18.833 | 19.072 | 21.521 | 19.801 | 25.214 | 17.392 | 19.168 | 25.811 | 41.562 |
| Gross Profit/Loss - EUR | 6.862 | 7.856 | 11.956 | 16.313 | 24.804 | 13.517 | 16.138 | 23.034 | 23.273 | 6.746 |
| Net Profit/Loss - EUR | 6.366 | 7.589 | 11.645 | 15.935 | 24.358 | 13.130 | 15.809 | 22.621 | 22.807 | 5.326 |
| Employees | 2 | 0 | 3 | 0 | 2 | 3 | 0 | 2 | 2 | 3 |
Check the financial reports for the company - Avepop Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.008 | 1.174 | 510 | 283 | 3.152 | 2.507 | 1.879 | 1.382 | 1.774 | 1.967 |
| Current Assets | 13.377 | 13.168 | 17.111 | 28.972 | 22.702 | 16.658 | 16.312 | 22.900 | 24.609 | 7.132 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.653 | 1.440 | 6.194 | 21.521 | 9.882 | 8.386 | 5.075 | 17.666 | 21.676 | 5.829 |
| Cash | 11.724 | 11.728 | 10.917 | 7.450 | 12.820 | 8.272 | 11.238 | 5.234 | 2.933 | 1.303 |
| Shareholders Funds | 14.494 | 7.642 | 11.715 | 27.435 | 24.461 | 13.232 | 16.013 | 22.826 | 23.012 | 5.529 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 891 | 6.700 | 5.906 | 1.820 | 1.394 | 5.933 | 2.179 | 1.456 | 3.371 | 3.569 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Avepop Medical Srl